Fayez Sarofim & CO Nautilus Biotechnology, Inc. Transaction History
Fayez Sarofim & CO
- $38.8 Billion
- Q1 2025
A detailed history of Fayez Sarofim & CO transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Fayez Sarofim & CO holds 45,000 shares of NAUT stock, worth $31,499. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,000Holding current value
$31,499% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NAUT
# of Institutions
91Shares Held
63.9MCall Options Held
28.5KPut Options Held
6K-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$11.4 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$8.82 Million0.45% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$5.02 Million0.19% of portfolio
-
Madrona Venture Group, LLC6.02MShares$4.21 Million18.2% of portfolio
-
Black Rock Inc. New York, NY3.83MShares$2.68 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $87.3M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...